Tumor edge-to-core transition promotes malignancy in primary-to-recurrent glioblastoma progression in a PLAGL1/CD109-mediated mechanism is a research paper published in Neuro-Oncology Advances (2020). On theSindex it has a DataRank of 0. It has been cited 21 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
National Institutes of Health
Grant: R01NS083767
National Institutes of Health
Grant: R01NS087913
National Institutes of Health
Grant: R01CA183991
National Institutes of Health
Grant: R01CA201402
Ministry of Health & Welfare, Republic of Korea
Grant: HI14C3418
NICHD NIH HHS
Grant: P50 HD103557
NCI NIH HHS
Grant: P50 CA211015
National Institutes of Health
Grant: 5R01NS087913-04
Metabolism Informs Intertumoral & Intratumoral Heterogeneity
National Institutes of Health
Grant: 5R01NS083767-05
Targeting MELK-mediated EZH2 signaling in glioma stem cells
National Institutes of Health
Grant: 5R01CA201402-07
The unique roles of the GTP-binding/protein crosslinking enzyme transglutaminase-2 and signaling partners in aggressive cancers
National Institutes of Health
Grant: 5R01CA183991-03
Novel role of compensatory proliferation in human brain tumor
Korea Health Industry Development Institute
Dr. Miriam and Sheldon G. Adelson Medical Research Foundation
FWCI
1.35
Citation Percentile
0.8%
Citation Trend
Fields of Study
Keywords
Sustainable Development Goals